Bubonic, septicemic and pneumonic plague are three clinical forms of the same infection, caused by Yersinia pestis. The names describe where the infection is principally affecting the body: lymph nodes, bloodstream or lungs. They are not three different bacteria, and one form can progress into another without prompt treatment.
The distinction matters because symptoms, routes of exposure and transmission risk differ. Pneumonic plague is the only form that can spread from person to person through infectious respiratory particles. All suspected forms require urgent medical assessment; a web page cannot diagnose plague.
What is the difference between the three forms of plague?
| Form | Main site affected | Hallmark pattern | Typical incubation described by CDC | Person-to-person spread |
|---|---|---|---|---|
| Bubonic | Lymphatic system | Sudden fever with one or more painful, swollen lymph nodes called buboes | Usually 2–8 days | Not the usual route |
| Septicemic | Bloodstream | Fever, profound weakness, abdominal symptoms, shock or bleeding into skin and organs | Poorly defined; likely within days | Not the usual route |
| Pneumonic | Lungs | Rapidly developing pneumonia, shortness of breath, chest pain and cough | Usually 1–3 days after inhalation; WHO notes it can be as short as 24 hours | Yes, through close exposure to infectious respiratory particles |
This comparison is a reading aid, not a diagnostic checklist. Early symptoms can be nonspecific, and septicemic plague may occur without a visible bubo. Laboratory testing is required to confirm Y. pestis.
What is bubonic plague?
Bubonic plague is the most common clinical form. It most often follows the bite of an infected flea. The bacteria move through the lymphatic system to a nearby lymph node, where they multiply and cause the node to become inflamed, tense and painful. That swollen node is called a bubo.
CDC lists fever, headache, chills, weakness and one or more swollen, painful lymph nodes among the characteristic features. The usual incubation period is two to eight days. Without appropriate antibiotics, bacteria can spread from the lymph nodes into the bloodstream or lungs, producing secondary septicemic or pneumonic disease.
Bubonic plague is not normally transmitted directly between people. That does not make it mild: WHO describes untreated plague as potentially severe and emphasizes early diagnosis and antibiotic treatment. See the site’s fuller guide to plague symptoms and the animal–flea cycle in how plague moves between animals, fleas and people.
What is septicemic plague?
Septicemic plague occurs when Y. pestis multiplies in the bloodstream. It can begin as the primary presentation after exposure or develop when another form spreads. A person may therefore have septicemic plague without first noticing a swollen lymph node.
CDC describes fever, chills, extreme weakness, abdominal pain, shock and possible bleeding into the skin or organs. Tissue damage can affect fingers, toes or the nose. The incubation period is less clearly defined than for bubonic or pneumonic plague but is thought to occur within days of exposure.
These findings overlap with other medical emergencies. The important public-health point is not to identify septicemic plague from an online list; it is that suspected plague combined with compatible illness needs immediate professional evaluation and laboratory coordination.
What is pneumonic plague?
Pneumonic plague affects the lungs and is the most urgent form from both a clinical and public-health perspective. It can be primary, after inhaling infectious respiratory particles, or secondary, when bacteria spread to the lungs from untreated bubonic or septicemic disease.
CDC describes fever, headache and weakness followed by rapidly developing pneumonia with shortness of breath, chest pain, cough and sometimes bloody or watery mucus. Following inhalation, the incubation period is usually one to three days; WHO states that it can be as short as 24 hours.
Pneumonic plague is the only form of plague that can spread between people. Transmission typically requires direct and close exposure to respiratory particles from a person or animal with plague pneumonia. This is not the same as saying every cough near a plague case causes infection. Exposure assessment belongs to public-health and clinical teams, who consider distance, duration, symptoms, protective equipment and the timing of contact.
Can one form of plague turn into another?
Yes. The categories describe the main clinical site at a given stage, not sealed compartments. Untreated bubonic plague can spread through the blood, producing septicemic plague, or seed the lungs, producing secondary pneumonic plague. Septicemic disease can also involve the lungs.
This progression is why a map or case count should not treat the three labels as unrelated diseases. It is also why a report may change classification as clinical and laboratory information becomes available. Our methodology separates a report’s evidence status from its disease form and event phase.
How is plague confirmed?
Symptoms and exposure history can raise suspicion, but confirmation requires laboratory testing. WHO describes testing samples such as fluid from a bubo, blood or sputum. CDC advises clinicians to involve public-health authorities when plague is suspected and notes that treatment decisions may need to begin from the clinical picture before every result is complete.
A negative result, an untested report and a ruled-out event are not interchangeable. Read why “unknown” is not zero for the data distinctions used throughout Plague Map.
When should someone seek medical help?
If you may have been exposed to plague and develop compatible symptoms, seek urgent medical care and contact local public-health services. Do not wait for an online map or article to confirm the cause.
Plague is treatable with antibiotics, but timing is critical. WHO and CDC both emphasize rapid diagnosis and treatment, particularly for pneumonic and septicemic disease. People should not use leftover antibiotics or attempt to select treatment from internet advice; clinicians must choose therapy based on the patient, exposure, local guidance and public-health consultation.
For practical exposure-reduction guidance, see plague prevention. For a concise explanation of each route, see how plague is transmitted.